The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs ...
The eye condition, known as non-arteritic anterior ischemic optic neuropathy, has been reported with all GLP-1 drugs. It can ...
What if you started taking a medication to manage diabetes or lose weight, only to learn it carries a potential risk of ...
The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss.
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased ...
Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in obesity and diabetes care.
The Food and Drug Administration is requiring updated safety labels on all GLP-1 medications because of a possible link to a ...
WHEN YOU LOSE weight through traditional diet and exercise, you tend to see a gradual slimming down of your face. But when ...
Weight loss can ease foot pain, but it can also leave you with less cushioning and looser shoes. Added padding and a better ...
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical ...
Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 diabetes trial.
A grandad who says he would never have taken Ozempic if he had been warned about the risk of sight loss is among more than 200 people taking legal action against its maker ...